Clinical Trial Update: Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating transplantation of mesenchymal stem cells in patients with relapsed or refractory aplastic anemia; the current status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Mesenchymal stem cell transplantation (mesenchymal stem cells)

Snippet

Sponsor: Guangzhou General Hospital of Guangzhou Military Command | Conditions: Aplastic Anemia | Phase 1, Phase 2 | Status: UNKNOWN